DSM Integrated Annual Report 2022

4 Segment information

Following the Health, Nutrition & Bioscience (HNB) structure becoming effective as of 1 January 2022, DSM’s reportable operating segments were Animal Nutrition & Health (ANH), Health, Nutrition & Care (HNC) and Food & Beverage (F&B) in 2022. These operating segments mainly comprise the former operating segments Nutrition and Innovation. The Materials business also continued to be a reportable operating segment throughout part of 2022; however, following the announced sale of this business, it was reclassified to ‘discontinued operations’ in the first half of 2022.

DSM has segmented its operations by business activity from which revenues are earned and expenses incurred. These operating results are regularly reviewed by the entity’s Chief Operating Decision Maker (CODM) to make decisions about resources to be allocated to the operating segment and assess its performance. DSM uses Adjusted EBITDA as the main indicator to evaluate the consolidated performance as well as the performance per operating segment. Discrete financial information is available for each identified operating segment.

The accounting policies of the operating segments are the same as those described in the Summary of significant accounting policies. Transactions between segments are generally executed at market-based prices. Interest income, interest expense, and income tax expense or income are not allocated to segments as these amounts are not included in the measure of segment profit or loss reviewed by the CODM, or otherwise regularly provided to the CODM.

Our operating segment Animal Nutrition & Health (ANH) drives the development of sustainable animal farming through its essential products, performance solutions, and precision services serving the poultry, swine, ruminants and aquaculture market segments around the globe.

Our operating segment Health, Nutrition & Care (HNC) provides health, nutrition and care solutions for markets such as early life nutrition, dietary supplements, pharma, medical and personal care.

Our operating segment Food & Beverage (F&B) supports healthy diets through nutritious, delicious and sustainable solutions for several market segments including bakery, beverages & brewing, dairy, savory, plant-based alternative proteins and pet food.

Any consolidated activities outside the three reportable operating segments above are reported as the reportable segment ‘Corporate Activities’. These consist of operating and service activities that are considered unallocated activities.

Following the change in the composition of DSM’s reportable segments in 2022 due to the HNB structure becoming effective, for each individual line item of disclosure, DSM applied the guidance provided in IFRS8.29-30 in assessing whether to restate the comparative segment information based on the information available. The 2021 segmentation comparatives that have been restated relate to the previously reported operating segment Innovation Center in 2021. This was restated for the purposes of comparison by redistributing the amounts to HNB and Corporate Activities.

DSM does not have a single external customer that represents 10% or more of total sales.

Geographical information

 

 

Nether­lands

 

Switzer­land

 

Rest of Europe

 

North America

 

Latin America

 

China

 

Rest of Asia

 

Rest of the world

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales (by destination)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

In € million

 

355

 

157

 

1,912

 

1,535

 

1,170

 

792

 

1,074

 

274

 

7,269

In %

 

5

 

2

 

26

 

21

 

16

 

11

 

15

 

4

 

100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Workforce at year-end (headcount)1

 

3,006

 

2,174

 

4,161

 

3,018

 

2,290

 

4,704

 

1,709

 

296

 

21,358

Intangible assets and Property, plant and equipment (carrying amount)

 

1,990

 

1,733

 

2,079

 

2,201

 

291

 

836

 

113

 

30

 

9,273

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales (by destination)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

In € million

 

402

 

156

 

2,154

 

1,869

 

1,507

 

803

 

1,188

 

311

 

8,390

In %

 

5

 

2

 

25

 

22

 

18

 

10

 

14

 

4

 

100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Workforce at year-end (headcount)1

 

2,642

 

2,232

 

4,211

 

2,618

 

2,302

 

4,591

 

1,742

 

344

 

20,682

Intangible assets and Property, plant and equipment (carrying amount)

 

1,304

 

1,852

 

2,099

 

2,143

 

404

 

774

 

113

 

34

 

8,723

1

Refers to total group, including discontinued operations.

Business segments

The following table represents the financial performance of the business segments based on the operating segments that existed in 2021, and as disclosed in the Integrated Annual Report 2021.

 

 

Nutrition

 

Innovation Center

 

Corporate Activities

 

Total continuing operations

 

Discontinued operations

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

Financial performance

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

7,031

 

168

 

70

 

7,269

 

2,199

 

9,468

Adjusted EBITDA1

 

1,447

 

26

 

(94)

 

1,379

 

463

 

1,842

EBITDA

 

1,396

 

17

 

(125)

 

1,288

 

1,082

 

2,370

Adjusted operating profit1

 

940

 

4

 

(136)

 

808

 

359

 

1,167

Operating profit

 

889

 

(10)

 

(168)

 

711

 

978

 

1,689

R&D costs

 

 

 

 

 

 

 

255

 

 

 

 

Adjusted EBITDA margin (in %)

 

20.6

 

 

 

 

 

19.0

 

21.1

 

19.5

1

See Note 2 Alternative performance measures for the reconciliation to IFRS performance measures.

In the below table, the amounts that were included in the previously reported operating segment Innovation Center have been redistributed to HNB and Corporate Activities for the purposes of comparison.

 

 

Animal Nutrition & Health

 

Health, Nutrition & Care

 

Food & Beverage

 

Other

 

Total HNB

 

Corporate Activities

 

Total continuing operations

 

Discontinued operations

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial performance

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

3,347

 

2,516

 

1,256

 

47

 

7,166

 

103

 

7,269

 

2,199

 

9,468

Adjusted EBITDA1

 

 

 

 

 

 

 

 

 

1,467

 

(88)

 

1,379

 

463

 

1,842

EBITDA

 

 

 

 

 

 

 

 

 

1,416

 

(128)

 

1,288

 

1,082

 

2,370

Adjusted operating profit1

 

 

 

 

 

 

 

 

 

951

 

(143)

 

808

 

359

 

1,167

Operating profit

 

 

 

 

 

 

 

 

 

900

 

(189)

 

711

 

978

 

1,689

R&D costs

 

 

 

 

 

 

 

 

 

 

 

 

 

255

 

 

 

 

Adjusted EBITDA margin (in %)

 

 

 

 

 

 

 

 

 

20.5

 

 

 

19.0

 

21.1

 

19.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial performance

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

3,788

 

2,939

 

1,546

 

46

 

8,319

 

71

 

8,390

 

2,090

 

10,480

Adjusted EBITDA1

 

546

 

676

 

266

 

2

 

1,490

 

(95)

 

1,395

 

330

 

1,725

EBITDA

 

523

 

667

 

245

 

2

 

1,437

 

(133)

 

1,304

 

1,342

 

2,646

Adjusted operating profit1

 

351

 

428

 

136

 

1

 

916

 

(149)

 

767

 

304

 

1,071

Operating profit

 

328

 

419

 

115

 

1

 

863

 

(181)

 

682

 

1,312

 

1,994

R&D costs

 

 

 

 

 

 

 

 

 

 

 

 

 

280

 

 

 

 

Adjusted EBITDA margin (in %)

 

14.4

 

23.0

 

17.2

 

 

 

17.9

 

 

 

16.6

 

15.8

 

16.5

1

See Note 2 Alternative performance measures for the reconciliation to IFRS performance measures.

CODM
Chief Operating Decision Maker
EBITDA
Earnings Before Interest, Taxes, Depreciation and Amortization